Peptide record

TPDB92529

iRGD Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92529
iRGD
Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Cancer-related peptides Delivery and barrier-penetrating peptides
Peptipedia BBPpredict CPPsite3.0 MLCPP 2.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 9-aa modified multi-activity (Anticancer, Blood-Brain Barrier, Cell-penetrating Peptides, and other sources) peptide sequence curated from Peptipedia, BBPpredict, CPPsite3.0, and other sources, with an available 3D structural model.
C-terminal: Diosgenin(DGN)
Sequence
CRGDKGPDC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
Diosgenin(DGN) Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Targeting
Alpha-5 beta -3 integrins, Neuropilin-1

Source & Reference

TumorHoPe2.0
TumorHoPe2
Targeted Delivery of Dual Anticancer Drugs Based on Self-Assembled iRGD-Modified Soluble Drug-Polymer Pattern Conjugate Nanoparticles
2021
Li C et al. ACS Appl Bio Mater. 2021 Feb 15 4(2):1499-1507

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
LLC, B16
Mice bearing B16 tumor
Synthetic
PEG-DGN
Additional Detail Fields 3 fields
PEG-DGN
LLC, B16
Mice bearing B16 tumor